Exicure (XCUR) Revenue Growth (1y) (2017 - 2022)
Exicure (XCUR) Revenue Growth (1y) (2017 - 2022) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Revenue Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
37.90% |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
64.24% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
7.82% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Exicure |
17.53 Mn |
14.92 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2022 |
1,128.05% |
| Sep 30, 2022 |
-45.17% |
| Jun 30, 2022 |
3,027.85% |
| Mar 31, 2022 |
157.27% |
| Dec 31, 2021 |
-1,612.86% |
| Sep 30, 2021 |
50.51% |
| Jun 30, 2021 |
-98.37% |
| Mar 31, 2021 |
-89.14% |
| Dec 31, 2020 |
-54.84% |
| Sep 30, 2020 |
363.57% |
| Jun 30, 2020 |
1,016.82% |
| Mar 31, 2020 |
36,632.00% |
| Dec 31, 2019 |
5,066.67% |
| Sep 30, 2019 |
824.56% |
| Jun 30, 2019 |
2,184.21% |
| Mar 31, 2019 |
-30.56% |
| Dec 31, 2018 |
-99.71% |
| Jun 30, 2018 |
-99.29% |
| Mar 31, 2018 |
-98.52% |
| Dec 31, 2017 |
203.62% |
